XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Restricted stock transactions and outstanding
Restricted stock transactions and outstanding awards are summarized as follows:
 
Years Ended September 30,
 
2014
 
2013
 
2012
 
Awards
 
Weighted Average Grant Date Fair Value
 
Awards
 
Weighted Average Grant Date Fair Value
 
Awards
 
Weighted Average Grant Date Fair Value
Beginning Outstanding
69,154

 
$
10.13

 
127,975

 
$
9.06

 
120,970

 
$
9.42

Awarded

 

 

 

 
60,600

 
7.98

Released
(33,951
)
 
10.13

 
(58,771
)
 
7.81

 
(51,595
)
 
8.72

Forfeited

 

 
(50
)
 
7.98

 
(2,000
)
 
7.22

Ending Outstanding
35,203

 
$
10.13

 
69,154

 
$
10.13

 
127,975

 
$
9.06

Stock-based compensation plans
Stock-based compensation expense for the fiscal years ended September 30, 2014, 2013 and 2012 reduced the Company’s results of operations as follows:
 
 
Years Ended September 30,
 
2014
 
2013
 
2012
 
(dollars in thousands)
Effect on income before income taxes (1)
$
(795
)
 
$
(2,472
)
 
$
(1,763
)
Effect on income taxes
$
326

 
$
512

 
$
255

Effect on net income
$
(469
)
 
$
(1,960
)
 
$
(1,508
)

(1) Stock-based compensation expense is included in selling, general and administrative expense
Stock-based compensation plans are summarized in the table below:
Name of Plan
 
Shares Authorized
 
Shares Available
 
Options Outstanding
 
Plan Expiration
2007 Employee Stock Incentive Plan
 
2,300,000

 
850,892

 
856,394

 
Mar. 2020
1998 Employee Stock Option Plan
 
500,000

 

 
52,460

 
Jan. 2008
Non-Employee Directors Stock Option Plan
 
500,000

 
191,600

 
154,470

 
Mar. 2020
 
 
 

 
1,042,492

 
1,063,324

 
 
Stock option transactions and the options outstanding
Stock option transactions and the options outstanding are summarized as follows:
 
Years Ended September 30,
 
2014
 
2013
 
2012
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
Outstanding at beginning of period
1,059,567

 
$
6.71

 
891,293

 
$
9.37

 
611,384

 
$
10.02

Granted
272,906

 
7.01

 
312,850

 
2.95

 
285,400

 
7.98

Exercised
(263,643
)
 
4.31

 
(8,450
)
 
3.08

 
(600
)
 
5.33

Forfeited/canceled
(5,506
)
 
9.63

 
(136,126
)
 
15.75

 
(4,891
)
 
9.50

Outstanding at end of period
1,063,324

 
$
7.37

 
1,059,567

 
$
6.71

 
891,293

 
$
9.37

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at end of period
674,237

 
$
8.18

 
874,591

 
$
7.13

 
400,638

 
$
9.25

 
 
 
 
 
 
 
 
 
 
 
 
Weighted average grant-date fair value of options granted during the period
$
4.38

 
 
 
$
1.82

 
 
 
$
4.95

 
 
Stock options outstanding and exercisable
The following tables summarize information for stock options outstanding and exercisable as of September 30, 2014:
 
 
Options Outstanding
Range of Exercise
Prices
 
Number
Outstanding
 
Remaining
Contractual
Life
 
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
 
 
 
(in years)
 
 
 
(in thousands)
2.95-3.00
 
196,574

 
8.2
 
$
2.95

 
$
1,523

3.01-7.00
 
160,923

 
4.1
 
5.70

 
805

7.01-8.00
 
524,292

 
8.2
 
7.47

 
1,693

8.01-15.00
 
109,000

 
4.9
 
10.49

 
38

15.01-23.00
 
72,535

 
6.2
 
17.55

 

 
 
1,063,324

 
7.1
 
$
7.37

 
$
4,059

Vested and expected
 to vest as of
September 30, 2014
 
1,058,894

 
7.1
 
$
7.37

 
$
4,040


 
 
Options Exercisable
Range of Exercise
Prices
 
Number
Exercisable
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
(in thousands)
2.95-3.00
 
85,611

 
$
2.95

 
$
663

3.01-7.00
 
160,923

 
5.70

 
805

7.01-8.00
 
251,686

 
7.98

 
685

8.01-15.00
 
106,500

 
10.49

 

15.01 - 23.00
 
69,517

 
17.56

 

 
 
674,237

 
$
8.18

 
$
2,153